ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.40%
      US Tech 100
      19,540.80
      -0.19%
      Dow Jones
      42,175.11
      0.62%
      Brent Oil
      71.235
      0.40%
      Bitcoin
      65,510.48
      0.50%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      09/27/20247:03AMBusiness WireKioxia et MoDeCH mettent au point un système de sondage tridimensionnel
      09/27/20247:02AMGlobeNewswire Inc.KCEX Expands Global Crypto Trading Platform with New Reward Center and Daily Futures Trading Competitions
      09/27/20247:02AMAlliance NewsAlliance NewsTOP NEWS: Murdoch's REA ups fourth Rightmove offer to GBP6.2 billionLSE:RMVRightmove Plc
      09/27/20247:02AMAlliance NewsAlliance NewsTOP NEWS: Murdoch's REA ups fourth Rightmove offer to GBP6.2 billionLSE:RMVRightmove Plc
      09/27/20247:02AMAlliance NewsAlliance NewsTOP NEWS: Murdoch's REA ups fourth Rightmove offer to GBP6.2 billionASX:REARea Group Ltd
      09/27/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GLGlobe Life Inc
      09/27/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HLNCFHaleon PLC (PK)
      09/27/20247:00AMAlliance NewsAlliance NewsMerchants Trust optimistic on medium-term outlook amid healthy resultsLSE:MRCHMerchants Trust Plc
      09/27/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/27/20247:00AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)EU:SANSanofi
      09/27/20247:00AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:REGNRegeneron Pharmaceuticals Inc
      09/27/20247:00AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)NASDAQ:SNYSanofi
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsAMEX:IDVOAmplify CWP International Enhanced Dividend Income ETF
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsAMEX:DIVOAmplify CWP Enhanced Dividend Income ETF
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsAMEX:NDIVAmplify Natural Resources Dividend Income ETF
      09/27/20247:00AMBusiness WireMoving iMage Technologies Announces Fourth Quarter and Full Year Fiscal 2024 ResultsAMEX:MITQMoving iMage Technologies Inc
      09/27/20247:00AMGlobeNewswire Inc.OTC Markets Group Welcomes G Mining Ventures Corp. to OTCQXTSX:GMING Mining Ventures Corp
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsSOFR
      09/27/20247:00AMBusiness WireGenerate Capital Expands Leadership with Industry Experts
      09/27/20247:00AMGlobeNewswire Inc.United Steelworkers union call out Pierre Poilievre’s misleading attack on Pharmacare
      09/27/20247:00AMBusiness WireEndpoints News Announces the 2024 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsAMEX:YYYAmplify High Income ETF
      09/27/20247:00AMGlobeNewswire Inc.Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPDEU:SANSanofi
      09/27/20247:00AMGlobeNewswire Inc.Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual MeetingsNASDAQ:LYRALyra Therapeutics Inc
      09/27/20247:00AMBusiness WireSepterna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
      09/27/20247:00AMGlobeNewswire Inc.Prison management company CoreCivic honored as inmates restore 55,000th wheelchair for people in need
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsNASDAQ:HCOWAmplify Cash Flow High Income ETF
      09/27/20247:00AMGlobeNewswire Inc.Amplify ETFs Declares September Income Distributions for its Income ETFsAMEX:QDVOAmplify Cwp Growth and Income ETF
      09/27/20247:00AMGlobeNewswire Inc.Canadian Premium Sand Inc. Announces CFO TransitionTSXV:CPSCanadian Premium Sands Inc
      09/27/20247:00AMBusiness WireMarqeta to Announce Third Quarter 2024 Results on November 4, 2024NASDAQ:MQMarqeta Inc

      Your Recent History

      ASX
      ZRIWMD
      BOV
      BOXP34Q
      BXP
      Delayed Upgrade Clock